Status:
COMPLETED
Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
This study will involve up to 20 bilateral patients per surgeon. Patients will be assessed pre-operatively, and at subsequent visits (following the implantation of the intraocular lens in the second e...
Eligibility Criteria
Inclusion
- 21 years or older;
- need spherical correction between 10-30 Diopters (D);
- corneal astigmatism less than 0.75D as measured by keratometry;
- willing to sign an Informed Consent Form and complete all visits;
- pupil dilation greater than 6mm;
- expected Visual Acuity (measured in logMAR)=0.3 or better
Exclusion
- Women of childbearing potential;
- irregular corneal astigmatism;
- keratopathy/keratectasia;
- cornea inflammation or edema;
- cornea reshaping surgery;
- corneal dystrophy;corneal transplant;
- amblyopia;
- glaucoma;
- Retinal Pigment Epitheliopathy (RPE)/Macular changes;
- proliferative diabetic retinopathy
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00934622
Start Date
November 1 2007
Last Update
May 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134